{"id":240901,"date":"2026-07-15T05:03:38","date_gmt":"2026-07-15T10:03:38","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/07\/blood-based-test-can-predict-risk-of-developing-symptoms-of-alzheimers-up-to-a-decade-early"},"modified":"2026-07-15T05:03:38","modified_gmt":"2026-07-15T10:03:38","slug":"blood-based-test-can-predict-risk-of-developing-symptoms-of-alzheimers-up-to-a-decade-early","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/07\/blood-based-test-can-predict-risk-of-developing-symptoms-of-alzheimers-up-to-a-decade-early","title":{"rendered":"Blood-based test can predict risk of developing symptoms of Alzheimer\u2019s up to a decade early"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/blood-based-test-can-predict-risk-of-developing-symptoms-of-alzheimers-up-to-a-decade-early.jpg\"><\/a><\/p>\n<p>A blood test for the biomarker phosphorylated tau 217 (p-tau217) recently received federal clearance, but questions have emerged about the extent to which such tests can accurately predict whether a cognitively healthy individual will develop cognitive impairment\u2014a key symptom of Alzheimer\u2019s disease.<\/p>\n<p>A new international study involving researchers across three continents and led by experts from the Mass General Brigham Neuroscience Institute sheds new light on the prognostic value of such tests.<\/p>\n<p>The study found that cognitively unimpaired individuals with very high levels of the biomarker had a 38% absolute risk of developing cognitive impairment over the next five years and a 78% risk over the next 10 years.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A blood test for the biomarker phosphorylated tau 217 (p-tau217) recently received federal clearance, but questions have emerged about the extent to which such tests can accurately predict whether a cognitively healthy individual will develop cognitive impairment\u2014a key symptom of Alzheimer\u2019s disease. A new international study involving researchers across three continents and led by experts [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,47],"tags":[],"class_list":["post-240901","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/240901","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=240901"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/240901\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=240901"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=240901"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=240901"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}